| Jun 6 |
Why Is Beam Therapeutics (BEAM) Up 10.1% Since Last Earnings Report?
|
| Jun 6 |
Here's Why Biogen Inc. (BIIB) is a Strong Momentum Stock
|
| Jun 5 |
Biogen favored at RBC as Eli Lilly awaits FDA AdCom on Alzheimer’s drug
|
| Jun 3 |
Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel
|
| May 31 |
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
|
| May 31 |
Repligen (RGEN) Down 10.9% Since Last Earnings Report: Can It Rebound?
|
| May 31 |
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
|
| May 31 |
How To Invest: Using Shorter-Term Moving Averages To Trade Stocks
|
| May 31 |
European Commission approves Biogen’s QALSODY for ALS treatment
|
| May 30 |
EU approves Biogen treatment for genetic form of ALS
|
